Analyst Ratings for Scribe Therapeutics Inc (SCTX)
SCTX Rating Summary
SCTX Price Target Summary
- Highest: $60.00 (Wells Fargo)
- Lowest: $50.00 (Guggenheim)
- Average: $57.00
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$57.00 (+169.2%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
Avg. $ Target:
$57.00 (+169.2%)
* Over Last 12-Mos
Rating Score: 8 / 10
Percentile Rank: 83%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/31/2026 | H.C. Wainwright | N/A | New Coverage | Buy (N/A) |
60.00 (N/A) |
28.44 (21.17) |
-25.56% | Details |
| 8/18/2026 | Leerink » Updated 8/25/2026 |
David Risinger | New Coverage | Outperform (N/A) |
58.00 (37.00) |
21.19 (21.17) |
-0.09% | Details |
 |
||||||||
|
||||||||
|
||||||||
